Safety and immunogenicity of a measles-vectored SARS-CoV-2 vaccine candidate, V591 / TMV-083, in healthy adults: results of a randomized, placebo-controlled Phase I study

Added 122 days ago (20.01.2022)
Authors: Odile Launay; Cécile Artaud; Marie Lachâtre; Mohand Ait-Ahmed; Jelle Klein; Liem Binh Luong Nguyen; Christine Durier; Bastiaan Jansen; Yvonne Tomberger; Nathalie Jolly; Anna Grossmann; Houda Tabbal; Jérémy Brunet; Marion Gransagne; Zaineb Choucha; Damien Batalie; Ana Delgado; Matthias Müllner; Roland Tschismarov; Pieter-Jan Berghmans; Annette Martin; Katrin Ramsauer; Nicolas Escriou; Christiane Gerke
Journal: EBioMedicine
Read article